VGVanesa Garrido-Rodríguez
Vanesa Garrido-Rodríguez
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vanesa Garrido-Rodríguez has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ana Isabel Alvarez-Rios
Servicio de Bioquímica, Hospital Universitario Virgen del Rocío, Sevilla, Spain
1 shared publication - Angel Bulnes-Ramos
Servicio de Inmunología, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain
1 shared publication - Anna Rull
Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
1 shared publication Carlos López-Gómez
1 shared publicationCristina Rodríguez-Díaz
1 shared publication- Daniel Enrique Di Zeo-Sánchez
Centro de Investigación Biomédico en Red Enfermedades Hepáticas y Digestivas (CIBERehd) Madrid Spain
1 shared publication
Latest Publications
- Open Access
- 24 April 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (7) , 4233-4260
The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system
- 24 April 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (7) , 4233-4260
Open AccessThe gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system
- Open Access
- 23 August 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (6) , 854-867
The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function
- 23 August 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (6) , 854-867
Open AccessThe persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function